Premium
Letter: bias in clinical trials of the symptomatic effects of the low FODMAP diet for irritable bowel syndrome—getting the facts right. Authors' reply
Author(s) -
Krogsgaard L. R.,
Lyngesen M.,
Bytzer P.
Publication year - 2017
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.14165
Subject(s) - irritable bowel syndrome , medicine , gastroenterology , clinical trial